| Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines V Grégoire, K Ang, W Budach, C Grau, M Hamoir, JA Langendijk, A Lee, ... Radiotherapy and Oncology 110 (1), 172-181, 2014 | 886 | 2014 |
| CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines V Grégoire, P Levendag, KK Ang, J Bernier, M Braaksma, V Budach, ... Radiotherapy and oncology 69 (3), 227-236, 2003 | 850 | 2003 |
| Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial J Overgaard, HS Hansen, L Specht, M Overgaard, C Grau, E Andersen, ... The Lancet 362 (9388), 933-940, 2003 | 832 | 2003 |
| Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up JP Machiels, CR Leemans, W Golusinski, C Grau, L Licitra, V Gregoire Annals of Oncology 31 (11), 1462-1475, 2020 | 696 | 2020 |
| Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe W Habre, N Disma, K Virag, K Becke, TG Hansen, M Jöhr, B Leva, ... The Lancet Respiratory Medicine 5 (5), 412-425, 2017 | 671 | 2017 |
| CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines CL Brouwer, RJHM Steenbakkers, J Bourhis, W Budach, C Grau, ... Radiotherapy and Oncology 117 (1), 83-90, 2015 | 639 | 2015 |
| Phase II study on stereotactic body radiotherapy of colorectal metastases M Hoyer, H Roed, A Traberg Hansen, L Ohlhuis, J Petersen, H Nellemann, ... Acta oncologica 45 (7), 823-830, 2006 | 504 | 2006 |
| Cervical lymph node metastases from unknown primary tumours: results from a national survey by the Danish Society for Head and Neck Oncology C Grau, LV Johansen, J Jakobsen, P Geertsen, E Andersen, BB Jensen Radiotherapy and Oncology 55 (2), 121-129, 2000 | 470 | 2000 |
| Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the … HM Nielsen, M Overgaard, C Grau, AR Jensen, J Overgaard Journal of clinical oncology 24 (15), 2268-2275, 2006 | 435 | 2006 |
| Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis B Lacas, J Bourhis, J Overgaard, Q Zhang, V Grégoire, M Nankivell, ... The Lancet Oncology 18 (9), 1221-1237, 2017 | 373 | 2017 |
| Delineation of the primary tumour clinical target volumes (ctv-p) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: Airo, caca, dahanca … V Grégoire, M Evans, QT Le, J Bourhis, V Budach, A Chen, A Eisbruch, ... Radiotherapy and Oncology 126 (1), 3-24, 2018 | 365 | 2018 |
| International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma AW Lee, WT Ng, JJ Pan, SS Poh, YC Ahn, H AlHussain, J Corry, C Grau, ... Radiotherapy and Oncology 126 (1), 25-36, 2018 | 328 | 2018 |
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group B Lacas, A Carmel, C Landais, SJ Wong, L Licitra, JS Tobias, B Burtness, ... Radiotherapy and Oncology 156, 281-293, 2021 | 301 | 2021 |
| Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters K Jensen, K Lambertsen, C Grau Radiotherapy and Oncology 85 (1), 74-82, 2007 | 286 | 2007 |
| Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy CN Andreassen, C Grau, JC Lindegaard Seminars in radiation oncology 13 (1), 62-72, 2003 | 285 | 2003 |
| Cancer of the nasal cavity and paranasal sinuses: a clinico-pathological study of 277 patients G Harbo, C Grau, T Bundgaard, M Overgaard, O Elbrønd, H Søgaard, ... Acta Oncologica 36 (1), 45-50, 1997 | 229 | 1997 |
| The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis JM Borras, Y Lievens, P Dunscombe, M Coffey, J Malicki, J Corral, ... Radiotherapy and Oncology 116 (1), 38-44, 2015 | 223 | 2015 |
| Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 study J Johansen, S Buus, A Loft, S Keiding, M Overgaard, HS Hansen, C Grau, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2008 | 218 | 2008 |
| Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey C Grau, N Defourny, J Malicki, P Dunscombe, JM Borras, M Coffey, ... Radiotherapy and Oncology 112 (2), 155-164, 2014 | 216 | 2014 |
| The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial P Lassen, JG Eriksen, A Krogdahl, MH Therkildsen, BP Ulhøi, ... Radiotherapy and Oncology 100 (1), 49-55, 2011 | 215 | 2011 |